IB
HZNP

Intrust Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Intrust Bank’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,534
Closed -$1.45M – 388
2023
Q3 		$1.45M Sell
12,534
-435
-3% -$46.7K 0.18% 100
2023
Q2 		$1.33M Sell
12,969
-717
-5% -$75.6K 0.16% 116
2023
Q1 		$1.49M Sell
13,686
-2,490
-15% -$275K 0.19% 105
2022
Q4 		$1.84M Buy
16,176
+1,354
+9% +$112K 0.26% 78
2022
Q3 		$917K Sell
14,822
-1,192
-7% -$83.3K 0.14% 138
2022
Q2 		$1.28M Sell
16,014
-2,444
-13% -$231K 0.18% 107
2022
Q1 		$1.94M Buy
18,458
+65
+0.4% +$6.33K 0.25% 76
2021
Q4 		$1.98M Buy
18,393
+585
+3% +$63.8K 0.24% 80
2021
Q3 		$1.95M Buy
17,808
+313
+2% +$32.5K 0.26% 79
2021
Q2 		$1.64M Buy
17,495
+124
+0.7% +$11.4K 0.22% 91
2021
Q1 		$1.6M Buy
17,371
+196
+1% +$16.5K 0.23% 87
2020
Q4 		$1.26M Buy
17,175
+231
+1% +$17.2K 0.19% 104
2020
Q3 		$1.32M Buy
16,944
+1,959
+13% +$135K 0.23% 88
2020
Q2 		$833K Buy
14,985
+661
+5% +$28.3K 0.17% 126
2020
Q1 		$424K Buy
14,324
+269
+2% +$9.1K 0.12% 183
2019
Q4 		$509K Buy
14,055
+108
+0.8% +$3.31K 0.12% 196
2019
Q3 		$380K Sell
13,947
-599
-4% -$15.5K 0.1% 227
2019
Q2 		$350K Sell
14,546
-1,120
-7% -$28.4K 0.09% 256
2019
Q1 		$414K Buy
15,666
+1,008
+7% +$23.9K 0.11% 237
2018
Q4 		$287K Buy
+14,658
New +$287K 0.08% 278

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Intrust Bank's HZNP Position: Q4 2023 in Review

Intrust Bank sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 12,534 shares — an estimated $1.45M sold.

Intrust Bank first reported a position in HZNP in Q4 2018 and held it in 20 quarters. The position peaked at $1.98M in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Intrust Bank reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Intrust Bank sold 12,534 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.45M.
  • Intrust Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 20 quarters.
  • Intrust Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.98M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Intrust Bank's 13F filing for Q4 2023, filed 5 Feb 2024.